Long-term therapy with Tysabri (natalizumab) significantly improved the mental state of people with secondary progressive multiple [...]
People with multiple sclerosis (MS) who feel stigmatized because of their condition are more likely to have depression, research presented [...]
The use of multiple sclerosis (MS) mobile apps by patients and their clinicians encourages shared decision-making and helps patients [...]
Multiple sclerosis (MS) patients who experienced a relapse between their first and second rounds of Lemtrada (alemtuzumab) had good [...]
A DRUG that helps the immune system destroy cancer has been developed by US scientists. It dramatically shrank deadly skin, brain and [...]
Having a disabling disease can making living very difficult, especially when the source of the disability is not well understood. Some [...]
